A
Abbott
Life-changing health technologies in the area of diagnostics, medical devices, nutritionals and branded generic medicines
About Abbott
Abbott Laboratories is a global healthcare company dedicated to improving lives through innovative medical technologies and health solutions. The company operates in several key areas, including cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's mission is to create life-changing technologies that are accessible and affordable, aiming to help people live their best lives.
Abbott serves a diverse range of clients, including hospitals, healthcare professionals, and patients. The company operates in the global healthcare market, which encompasses various sectors such as medical devices, diagnostics, and nutrition. Abbott's business model focuses on research and development to create advanced medical products and solutions that address critical health needs.
The company generates revenue through the sale of its medical devices, diagnostic tests, and nutritional products. For instance, Abbott's cardiovascular technologies help doctors manage heart health more effectively, while its diabetes care products allow patients to monitor their glucose levels accurately without painful fingersticks. In diagnostics, Abbott provides essential testing solutions that deliver timely information for better decision-making. Additionally, the company's neuromodulation products offer relief for chronic pain and movement disorders by targeting specific areas of the nervous system.
Abbott is also committed to sustainability, with a 2030 Sustainability Plan that prioritizes designing technologies for greater access and affordability. This commitment underscores the company's broader goal of making a positive impact on global health and well-being.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1888
- Headquarters
- North Chicago, United States
- Listing
- IPO 1980
- Employees
- 153,335
- Open positions
- 808
- Dealroom signal
- 43.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, DT and LS
- Technology
- Hardware, Deep Tech
- Client focus
- b2b, b2c
- Investment activity
- 34 companies, latest May 2026
- Capital deployed
- $914M
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Mar 2011 | $100K | — | Undisclosed | — |
| POST IPO DEBT✓Debt | Mar 2009 | $6.7M | — | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Abbott is 1.2M monthly website visits, up 27.7% over the last three months. Abbott's team declined 2.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
NVision QuantumUlm, GermanyQuantum-enhanced MRI for real-time metabolic imaging.
$152Mvaluation
WhoopBoston, United StatesWearable tech providing health, sleep and performance insights through biometric data tracking
$10Bvaluation
Exact SciencesMadison, United StatesDeveloper and manufacturer of cologuard, a non-invasive screening test for the early detection of colorectal cancer
$23Bvaluation
SetPoint MedicalSanta Clarita, United StatesDeveloping novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease and multiple sclerosis
$460Mvaluation
NVision Imaging TechnologiesUlm, GermanyA developer of quantum MRI agents and polarization devices for assessing early patient response to treatment at the metabolic level
$120Mvaluation
Bigfoot BiomedicalMilpitas, United StatesA new kind of medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes
$114Mvaluation
Cardiovascular SystemsSaint Paul, United StatesInnovative cardiovascular solutions for advanced PAD and CAD treatment, enhancing patient outcomes with cutting-edge technology
$728Mvaluation
AlereWaltham, United StatesKnowing now matters.™ We develop tests for #flu and other diseases that help patients by delivering reliable and actionable information.
→
St. Jude MedicalSaint Paul, United StatesManufactures medical devices for the treatment of epidemic diseases
$25Bvaluation
Kalila MedicalCampbell, United StatesKalila | Redefining Precision and Control
→
Tendyne HoldingsRockville, United StatesMedical device company developing a transcatheter aortic valve implantation system
$250Mvaluation
VeropharmVoronezh, Russia
$305Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors5 additional known investors
Apple Tree Partners
Auriga Partners (Paris)
EW Healthcare Partners
InterWest Partners
US Biomedical Advanced Research and Development Authority
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Abbott on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Abbott’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.